<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Landers JE</submitter><funding>NCRR NIH HHS</funding><funding>Howard Hughes Medical Institute</funding><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><pagination>9004-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2683883</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>106(22)</volume><pubmed_abstract>Amyotrophic lateral sclerosis is a degenerative disorder of motor neurons that typically develops in the 6th decade and is uniformly fatal, usually within 5 years. To identify genetic variants associated with susceptibility and phenotypes in sporadic ALS, we performed a genome-wide SNP analysis in sporadic ALS cases and controls. A total of 288,357 SNPs were screened in a set of 1,821 sporadic ALS cases and 2,258 controls from the U.S. and Europe. Survival analysis was performed using 1,014 deceased sporadic cases. Top results for susceptibility were further screened in an independent sample set of 538 ALS cases and 556 controls. SNP rs1541160 within the KIFAP3 gene (encoding a kinesin-associated protein) yielded a genome-wide significant result (P = 1.84 x 10(-8)) that withstood Bonferron</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.</pubmed_title><pmcid>PMC2683883</pmcid><funding_grant_id>U54 RR020278-01</funding_grant_id><funding_grant_id>G0600974</funding_grant_id><funding_grant_id>G0500289B</funding_grant_id><funding_grant_id>MC_G1000733</funding_grant_id><funding_grant_id>G0900688</funding_grant_id><funding_grant_id>U54 RR020278</funding_grant_id><funding_grant_id>G0500289</funding_grant_id><funding_grant_id>089701</funding_grant_id><pubmed_authors>Landers JE</pubmed_authors><pubmed_authors>Melki J</pubmed_authors><pubmed_authors>van den Berg LH</pubmed_authors><pubmed_authors>Shi L</pubmed_authors><pubmed_authors>Ticozzi N</pubmed_authors><pubmed_authors>Horvitz HR</pubmed_authors><pubmed_authors>Purcell S</pubmed_authors><pubmed_authors>Powell JF</pubmed_authors><pubmed_authors>Cho TJ</pubmed_authors><pubmed_authors>Wills AM</pubmed_authors><pubmed_authors>van Es MA</pubmed_authors><pubmed_authors>Hosler BA</pubmed_authors><pubmed_authors>Galan P</pubmed_authors><pubmed_authors>Hansen VK</pubmed_authors><pubmed_authors>Saris CG</pubmed_authors><pubmed_authors>Rodriguez-Leyva I</pubmed_authors><pubmed_authors>Couture N</pubmed_authors><pubmed_authors>Simpson CL</pubmed_authors><pubmed_authors>Cronin S</pubmed_authors><pubmed_authors>Silani V</pubmed_authors><pubmed_authors>Leigh PN</pubmed_authors><pubmed_authors>Meininger V</pubmed_authors><pubmed_authors>Glass JD</pubmed_authors><pubmed_authors>Shaw CE</pubmed_authors><pubmed_authors>Diekstra FP</pubmed_authors><pubmed_authors>van Vught PW</pubmed_authors><pubmed_authors>Ophoff RA</pubmed_authors><pubmed_authors>Ozoguz A</pubmed_authors><pubmed_authors>McKenna-Yasek DM</pubmed_authors><pubmed_authors>Kwiatkowski TJ</pubmed_authors><pubmed_authors>Corcia P</pubmed_authors><pubmed_authors>Heath S</pubmed_authors><pubmed_authors>Sapp PC</pubmed_authors><pubmed_authors>Barnes-Nessa A</pubmed_authors><pubmed_authors>Hardiman O</pubmed_authors><pubmed_authors>Salachas F</pubmed_authors><pubmed_authors>Georges F</pubmed_authors><pubmed_authors>Wokke JH</pubmed_authors><pubmed_authors>Blauw HM</pubmed_authors><pubmed_authors>Polak M</pubmed_authors><pubmed_authors>Ivinson AJ</pubmed_authors><pubmed_authors>Al-Chalabi A</pubmed_authors><pubmed_authors>Broom WJ</pubmed_authors><pubmed_authors>Veldink JH</pubmed_authors><pubmed_authors>Brown RH</pubmed_authors><pubmed_authors>Lathrop M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.</name><description>Amyotrophic lateral sclerosis is a degenerative disorder of motor neurons that typically develops in the 6th decade and is uniformly fatal, usually within 5 years. To identify genetic variants associated with susceptibility and phenotypes in sporadic ALS, we performed a genome-wide SNP analysis in sporadic ALS cases and controls. A total of 288,357 SNPs were screened in a set of 1,821 sporadic ALS cases and 2,258 controls from the U.S. and Europe. Survival analysis was performed using 1,014 deceased sporadic cases. Top results for susceptibility were further screened in an independent sample set of 538 ALS cases and 556 controls. SNP rs1541160 within the KIFAP3 gene (encoding a kinesin-associated protein) yielded a genome-wide significant result (P = 1.84 x 10(-8)) that withstood Bonferron</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Jun</publication><modification>2026-05-03T14:21:52.567Z</modification><creation>2026-04-21T03:10:15.645Z</creation></dates><accession>S-EPMC2683883</accession><cross_references><pubmed>19451621</pubmed><doi>10.1073/pnas.0812937106</doi></cross_references></HashMap>